Results 21 to 30 of about 968,831 (312)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

The perception of air pollution and its health risk: a scoping review of measures and methods

open access: yesGlobal Health Action
Background Although there is increasing awareness of the health risks of air pollution as a global issue, few studies have focused on the methods for assessing individuals’ perceptions of these risks.
Zeinab Bahrami   +10 more
doaj   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout

open access: yesFrontiers in Medicine
ObjectiveThe study focuses on comparing the efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout.MethodsA prospective, randomized, open-labeled trial of men with gout and renal uric acid
Caiyu Zheng   +9 more
doaj   +1 more source

Bettering Humanity through Biology [PDF]

open access: yes, 2018
Biology is arguably referred to as the “science of the XXIth century”. This prestigious title intrinsically contains a huge responsibility. For many centuries, Biology has contributed directly or indirectly to bettering humankind, although its obvious ...
Mota, Manuel
core  

“Humanism” [PDF]

open access: yesMonist, 1904
n ...
openaire   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial

open access: yesBMC Pharmacology and Toxicology
Background Interferons (IFNs) are proteins that combat viruses and regulate the immune system. Studies have demonstrated that aerosol inhalation of IFNα is both effective and safe for treating respiratory infections.
Wenqi Huang   +9 more
doaj   +1 more source

McMinnville Habitat for Humanity: Homeownership and Resources Survey [PDF]

open access: yes, 2009
This report outlines the overall satisfaction that homeowners feel in regards to their new homes provided through the Habitat for Humanity program. Details include the overall building experience for Habitat for Humanity homeowners, and the report also ...
Peterson, Jeff D.
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy